For most private deals, you cannot buy pre-IPO shares without being accredited. The vast majority of pre-IPO offerings in the United States are sold under securities exemptions that are open only to accredited investors, so accreditation is the gate that stands between a retail buyer and a stake in a private company before it lists. There are a few narrow, tightly capped exceptions where non-accredited investors can participate, but they are the exception, not the rule, and they come with limits most serious buyers outgrow quickly.

The good news: accreditation is a status, not a wealth club you are born into. Many people already qualify and simply never checked. Below is exactly what the SEC requires, why the rules work this way, where the non-accredited exceptions live, and how to confirm where you stand.

Private companies raise money without registering the offering with the SEC, which is what makes a private placement private. In exchange for skipping registration, issuers rely on exemptions (most commonly Regulation D, Rule 506(b)) that restrict who can buy. The logic is that accredited investors are presumed able to absorb the risk of an illiquid, non-public asset and to fend for themselves without the disclosures a public IPO requires.

Pre-IPO investing is a long game. Companies now stay private far longer than they used to, which means your capital can be locked up for years before any exit. We wrote about that structural shift in The 14-Year IPO. Accreditation exists precisely because this asset class asks you to hold risk that public-market investors never take on.

You are an accredited investor if you meet any one of the following. You do not need to satisfy all of them: a single qualifying route is enough.

Two clarifications worth locking in. First, these thresholds are unchanged in 2026 and are not indexed to inflation. The numbers are the same figures that have applied for years. Second, do not confuse accreditation with the separate qualified client standard under Rule 205-3, which changed in April 2026 and governs performance fees, not who may buy pre-IPO shares. They are different rules for different purposes.

For a fuller walkthrough with edge cases, see our help article on accreditation explained.

Possibly, but not yet. The INVEST Act (H.R. 3383) passed the U.S. House in December 2025 and now sits with the Senate. If it becomes law, it would add new pathways to accreditation based on licensing, education, and demonstrated experience, and would index the dollar thresholds going forward. As of now it is not law, so the criteria in the table above are what apply today. Treat any headline about "easier accreditation" as a proposal, not a rule.

Non-accredited investors are not entirely shut out of private companies. A handful of exemptions were designed to let the general public participate in early-stage fundraising, most notably regulation crowdfunding, which permits ordinary investors to back private issuers within annual limits tied to their income and net worth. These frameworks are real and legitimate.

They are also constrained by design. The per-investor caps are low, the universe of companies raising this way skews earlier and smaller, and the same illiquidity applies, so you still cannot easily sell what you buy. For most people the honest takeaway is this: these paths exist, but if you can qualify as accredited, the far larger and more established pre-IPO market opens up. That is usually the better use of your energy.

Legion Equity is a platform for accredited investors to invest in pre-IPO private companies through SPVs. Each deal is structured as a special purpose vehicle. Think of an SPV as a container that holds a single position so many investors can pool into one clean line on the cap table. If SPVs are new to you, start with understanding SPVs.

A few specifics on how it works:

Because Legion runs under Rule 506(b), participation is limited to accredited investors, and there is no non-accredited tier here. We are also an early-stage platform and some steps in the process are still handled manually; we would rather state that plainly than overpromise a frictionless experience we have not built yet. Legion also offers a private-markets data product, Alpha, covering valuations, secondary prints, and IPO odds, if you want to study the market before committing capital. When you are ready to walk through the mechanics, see how to get started as an LP.

In most cases, no. The bulk of pre-IPO offerings rely on exemptions restricted to accredited investors. Limited public exceptions like regulation crowdfunding let non-accredited investors participate within tight annual caps, but the broader pre-IPO market, including Legion, is accredited-only.

You qualify if you meet any single route: over $200,000 income individually (or $300,000 jointly) in each of the last two years, over $1,000,000 in net worth excluding your home, a Series 7/65/82 license, or an eligible entity or knowledgeable-employee route. Many people meet the net-worth test through retirement and investment accounts without realizing it.

Legion operates under Rule 506(b), where accreditation is self-certified: you attest to your status rather than submitting proof up front. A specific deal may request verification, and identity is confirmed via Persona in all cases.

Not directly, and not yet. The INVEST Act (H.R. 3383) passed the House in December 2025 and is with the Senate. It would broaden how someone becomes accredited, via licensing, education, or experience, rather than removing the accreditation requirement itself. It is not law today.

Generally no. Pre-IPO positions are illiquid and can stay locked up for years until an exit. Some platforms, including Legion, support a secondary market, but sales are subject to approval and are never guaranteed.

Ready to find out if you already qualify to invest in pre-IPO companies? Check if you qualify and join the waitlist.

This article is for educational purposes only and is not legal, tax, or investment advice. See our disclosures for details.